Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal …

P David, M Drabczyk-Pluta, E Pastille… - PLoS …, 2020 - journals.plos.org
P David, M Drabczyk-Pluta, E Pastille, T Knuschke, T Werner, N Honke, DA Megger…
PLoS pathogens, 2020journals.plos.org
Combination immunotherapy (CIT) is currently applied as a treatment for different cancers
and is proposed as a cure strategy for chronic viral infections. Whether such therapies are
efficient during an acute infection remains elusive. To address this, inhibitory receptors were
blocked and regulatory T cells depleted in acutely Friend retrovirus-infected mice. CIT
resulted in a dramatic expansion of cytotoxic CD4+ and CD8+ T cells and a subsequent
reduction in viral loads. Despite limited viral replication, mice developed fatal …
Combination immunotherapy (CIT) is currently applied as a treatment for different cancers and is proposed as a cure strategy for chronic viral infections. Whether such therapies are efficient during an acute infection remains elusive. To address this, inhibitory receptors were blocked and regulatory T cells depleted in acutely Friend retrovirus-infected mice. CIT resulted in a dramatic expansion of cytotoxic CD4+ and CD8+ T cells and a subsequent reduction in viral loads. Despite limited viral replication, mice developed fatal immunopathology after CIT. The pathology was most severe in the gastrointestinal tract and was mediated by granzyme B producing CD4+ and CD8+ T cells. A similar post-CIT pathology during acute Influenza virus infection of mice was observed, which could be prevented by vaccination. Melanoma patients who developed immune-related adverse events under immune checkpoint CIT also presented with expanded granzyme-expressing CD4+ and CD8+ T cell populations. Our data suggest that acute infections may induce immunopathology in patients treated with CIT, and that effective measures for infection prevention should be applied.
PLOS